Establishing schedules for repeated doses of strontium and for concurrent chemotherapy in hormone-resistant patients with prostate cancer: measurement of blood and urine strontium levels.

Abstract

Strontium-89 (Sr-89) alone or with concurrent chemotherapy has a role in the treatment of patients with prostate cancer (PCP). The schedules for repeated doses of Sr-89 or for concurrent chemotherapy is undetermined. The objective of this study was to measure the effective half-life (Te) of Sr-89 using a detector available in a nuclear research facility… (More)

Topics

4 Figures and Tables

Cite this paper

@article{BenYosef2005EstablishingSF, title={Establishing schedules for repeated doses of strontium and for concurrent chemotherapy in hormone-resistant patients with prostate cancer: measurement of blood and urine strontium levels.}, author={Rami Ben-Yosef and Omer Pelled and Rachel Marko and Akiva Vexler and Avi Teshuva and U. R. German and Moshe Levita and Rina Kol}, journal={American journal of clinical oncology}, year={2005}, volume={28 2}, pages={138-42} }